Publication | Open Access

Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction

Molecular PharmacologyBiochemistryMedicineNatural SciencesAntiviral Drug DevelopmentAntiviral TherapyVirologyBioactivity PredictionFree Energy CalculationsExtensive Molecular DockingAntiviral DrugPharmacologyAntiviral CompoundSmall MoleculesDrug Discovery